Neuland Labs gets USFDA EIR for Pashamylaram Manufacturing Facility
Hyderabad: Neuland Labs has received an Establishment Inspection Report (EIR) from the U.S.FDA for its manufacturing facility located at Pashamylaram, Hyderabad."The facility was inspected from 3 rd to 7th February 2020. The inspection has now been closed by the U.S. FDA," the company confirmed in a BSE filingNeuland Laboratories Limited was established in 1984 and is a publicly listed...
Login or Register to read the full article
Hyderabad: Neuland Labs has received an Establishment Inspection Report (EIR) from the U.S.FDA for its manufacturing facility located at Pashamylaram, Hyderabad.
"The facility was inspected from 3 rd to 7th February 2020. The inspection has now been closed by the U.S. FDA," the company confirmed in a BSE filing
Neuland Laboratories Limited was established in 1984 and is a publicly listed company headquartered in Hyderabad, India.
The company produces active pharmaceutical ingredients (APIs) and an end-to-end solution provider for the pharmaceutical industry's chemistry needs.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd